Federal Jury Awards $885M in Amitiza Pay-for-Delay Antitrust CaseMay 19, 2026VerdictsA Boston federal jury found Takeda Pharmaceutical liable for $885M in single damages in the Amitiza pay-for-delay antitrust class action, with trebled exposure nearing $2.6B.